You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

List of Excipients in API tafluprost opthalmic

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing tafluprost opthalmic

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC	Excipient
Micro Labs Limited	tafluprost opthalmic	42571-264	EDETATE DISODIUM
Micro Labs Limited	tafluprost opthalmic	42571-264	GLYCERIN
Micro Labs Limited	tafluprost opthalmic	42571-264	HYDROCHLORIC ACID
Micro Labs Limited	tafluprost opthalmic	42571-264	POLYSORBATE 80
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for tafluprost opthalmic

Excipient focus: EDETATE DISODIUM

tafluprost opthalmic drug variants containing EDETATE DISODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Micro Labs Limited	tafluprost opthalmic	42571-264
>Company	>Ingredient	>NDC

tafluprost opthalmic drug variants not containing EDETATE DISODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GLYCERIN

tafluprost opthalmic drug variants containing GLYCERIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Micro Labs Limited	tafluprost opthalmic	42571-264
>Company	>Ingredient	>NDC

tafluprost opthalmic drug variants not containing GLYCERIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

tafluprost opthalmic drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Micro Labs Limited	tafluprost opthalmic	42571-264
>Company	>Ingredient	>NDC

tafluprost opthalmic drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

tafluprost opthalmic drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Micro Labs Limited	tafluprost opthalmic	42571-264
>Company	>Ingredient	>NDC

tafluprost opthalmic drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

tafluprost opthalmic drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Micro Labs Limited	tafluprost opthalmic	42571-264
>Company	>Ingredient	>NDC

tafluprost opthalmic drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

tafluprost opthalmic drug variants containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Micro Labs Limited	tafluprost opthalmic	42571-264
>Company	>Ingredient	>NDC

tafluprost opthalmic drug variants not containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

tafluprost opthalmic drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Micro Labs Limited	tafluprost opthalmic	42571-264
>Company	>Ingredient	>NDC

tafluprost opthalmic drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.